Annual long term liabilities:
$188.94M+$16.52M(+9.58%)Summary
- As of today (September 15, 2025), AKBA annual total long term liabilities is $188.94 million, with the most recent change of +$16.52 million (+9.58%) on December 31, 2024.
- During the last 3 years, AKBA annual long term liabilities has fallen by -$5.35 million (-2.75%).
- AKBA annual long term liabilities is now -14.62% below its all-time high of $221.29 million, reached on December 31, 2022.
Performance
AKBA Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$197.65M+$3.28M(+1.69%)Summary
- As of today (September 15, 2025), AKBA quarterly total long term liabilities is $197.65 million, with the most recent change of +$3.28 million (+1.69%) on June 1, 2025.
- Over the past year, AKBA quarterly long term liabilities has increased by +$51.00 million (+34.78%).
- AKBA quarterly long term liabilities is now -28.36% below its all-time high of $275.91 million, reached on September 30, 2021.
Performance
AKBA quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AKBA Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.6% | +34.8% |
| 3 y3 years | -2.8% | -12.5% |
| 5 y5 years | +12.3% | +10.3% |
AKBA Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.6% | +9.6% | -15.6% | +34.8% |
| 5 y | 5-year | -14.6% | +12.3% | -28.4% | +34.8% |
| alltime | all time | -14.6% | >+9999.0% | -28.4% | >+9999.0% |
AKBA Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $197.65M(+1.7%) |
| Mar 2025 | - | $194.38M(+2.9%) |
| Dec 2024 | $188.94M(+9.6%) | $188.94M(-1.5%) |
| Sep 2024 | - | $191.84M(+30.8%) |
| Jun 2024 | - | $146.65M(-21.3%) |
| Mar 2024 | - | $186.25M(+8.0%) |
| Dec 2023 | $172.42M(-22.1%) | $172.42M(-11.5%) |
| Sep 2023 | - | $194.72M(+3.4%) |
| Jun 2023 | - | $188.34M(-9.6%) |
| Mar 2023 | - | $208.27M(-5.9%) |
| Dec 2022 | $221.29M(+13.9%) | $221.29M(-5.5%) |
| Sep 2022 | - | $234.08M(+3.7%) |
| Jun 2022 | - | $225.82M(-11.6%) |
| Mar 2022 | - | $255.33M(+31.4%) |
| Dec 2021 | $194.29M(-7.2%) | $194.29M(-29.6%) |
| Sep 2021 | - | $275.91M(+1.6%) |
| Jun 2021 | - | $271.64M(+12.2%) |
| Mar 2021 | - | $242.13M(+15.6%) |
| Dec 2020 | $209.38M(+24.4%) | $209.38M(+18.5%) |
| Sep 2020 | - | $176.72M(-1.3%) |
| Jun 2020 | - | $179.14M(+1.1%) |
| Mar 2020 | - | $177.20M(+5.3%) |
| Dec 2019 | $168.33M | $168.33M(+122.4%) |
| Sep 2019 | - | $75.70M(-14.4%) |
| Jun 2019 | - | $88.48M(-2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $90.50M(-56.4%) |
| Dec 2018 | $207.70M(+106.2%) | $207.70M(+147.6%) |
| Sep 2018 | - | $83.89M(+0.5%) |
| Jun 2018 | - | $83.44M(-11.4%) |
| Mar 2018 | - | $94.20M(-6.5%) |
| Dec 2017 | $100.75M(-14.5%) | $100.75M(+15.3%) |
| Sep 2017 | - | $87.36M(-11.1%) |
| Jun 2017 | - | $98.23M(+3.2%) |
| Mar 2017 | - | $95.18M(-19.2%) |
| Dec 2016 | $117.83M(>+9900.0%) | $117.83M(+178.8%) |
| Sep 2016 | - | $42.27M(+2.1%) |
| Jun 2016 | - | $41.41M(+2.8%) |
| Mar 2016 | - | $40.27M(>+9900.0%) |
| Dec 2015 | $74.00K(+131.3%) | $74.00K(+640.0%) |
| Sep 2015 | - | $10.00K(0.0%) |
| Jun 2015 | - | $10.00K(+11.1%) |
| Mar 2015 | - | $9000.00(-71.9%) |
| Dec 2014 | $32.00K(+300.0%) | $32.00K(-5.9%) |
| Sep 2014 | - | $34.00K(-5.3%) |
| Jun 2014 | - | $35.90K(-5.0%) |
| Mar 2014 | - | $37.80K(+372.5%) |
| Dec 2013 | $8000.00(>+9900.0%) | $8000.00(>+9900.0%) |
| Dec 2012 | $0.00(0.0%) | - |
| Dec 2012 | - | $0.00 |
| Dec 2011 | $0.00 | - |
FAQ
- What is Akebia Therapeutics, Inc. annual total long term liabilities?
- What is the all time high annual long term liabilities for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual long term liabilities year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly long term liabilities year-on-year change?
What is Akebia Therapeutics, Inc. annual total long term liabilities?
The current annual long term liabilities of AKBA is $188.94M
What is the all time high annual long term liabilities for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual total long term liabilities is $221.29M
What is Akebia Therapeutics, Inc. annual long term liabilities year-on-year change?
Over the past year, AKBA annual total long term liabilities has changed by +$16.52M (+9.58%)
What is Akebia Therapeutics, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of AKBA is $197.65M
What is the all time high quarterly long term liabilities for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly total long term liabilities is $275.91M
What is Akebia Therapeutics, Inc. quarterly long term liabilities year-on-year change?
Over the past year, AKBA quarterly total long term liabilities has changed by +$51.00M (+34.78%)